Healthcare ❯ Pharmaceuticals

Weight Loss

GLP-1 Medications Drugs GLP-1 Drugs Medications Drug Development GLP-1 Products GLP-1 Program Wegovy Semaglutide Treatment Comparison Body Weight Percentage GLP-1 Treatments GLP-1 Injections Health-Tech Partnerships

GSK Gains After Cramer Endorsement as Company Pushes Into Weight-Loss Drugs

The move underscores investor interest in its weight-loss push.

Eli Lilly Tightens GLP-1 Grip, Guides Up to $83 Billion for 2026

Eli Lilly’s Q4 Beat and Bullish Outlook Give Way to Stock Drop on Low-Cost GLP-1 Pills

Novo Nordisk Presses India Expansion and Higher-Dose Push as Analyst Views Diverge